| 000 | 01591 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514002921.0 | ||
| 264 | 0 | _c20010802 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0020-1669 | ||
| 024 | 7 |
_a10.1021/ic991259p _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBierbach, U | |
| 245 | 0 | 0 |
_aInversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate. _h[electronic resource] |
| 260 |
_bInorganic chemistry _cMay 2000 |
||
| 300 |
_a1882-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAcetates _xchemistry |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aChelating Agents _xchemistry |
| 650 | 0 | 4 |
_aCisplatin _xchemistry |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aGuanosine Monophosphate _xmetabolism |
| 650 | 0 | 4 |
_aLeukemia L1210 _xdrug therapy |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aMagnetic Resonance Spectroscopy _xmethods |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xchemical synthesis |
| 650 | 0 | 4 |
_aPyridines _xchemical synthesis |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aSabat, M | |
| 700 | 1 | _aFarrell, N | |
| 773 | 0 |
_tInorganic chemistry _gvol. 39 _gno. 9 _gp. 1882-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/ic991259p _zAvailable from publisher's website |
| 999 |
_c11357514 _d11357514 |
||